Allied BioScience

Capital7 Invests in Dallas Biotech Allied BioScience’s Series C Preferred Stock

by | May 11, 2021
The Series C funding brings Allied BioScience’s total to more than $80 million, the team told us. It will be used to grow the biotech's flagship product, SurfaceWise2, which is an active surface coating that can continuously destroy 99.9 percent of viruses on surfaces. Last year, SurfaceWise2 was the first and only surface coating that the EPA approved for continuous protection against COVID-19 with a single application.
How Allied BioScience’s Chief Marketing Officer Blurs a Traditional Work/Life Balance
by | Mar 8, 2021
As CMO at the Dallas-based biotech, Jessica Hilton is part of a team working to launch the first-ever long-lasting cleaner that can fight COVID-19. It's a job she took during the middle of the global pandemic—and though her home life looks a little different, the mom of three is managing it all through a deep-seeded passion and supportive family.
Allied BioScience’s Antimicrobial Surface Coating Becomes First Approved by EPA to Continuously Protect Against COVID-19
by | Aug 24, 2020
The U.S. Environmental Protection Agency has given approval to Allied BioScience for its electrostatic spraying solution, SurfaceWise2. The next-gen coating will give critical protection to Texas-based companies like early partner American Airlines.
Study Says: Dallas Biotech’s Antimicrobial Coating Linked with Health Care-Associated Infection Reduction
by | May 4, 2020
Last month, Allied BioScience received capital from Lydia Partners to scale its operations and meet a surging demand.